DR REDDYS LABORATORIES LTD — Share Issue/Capital Change 2025

Mar 6, 2025

==> picture [128 x 28] intentionally omitted <==

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India

CIN: L85195TG1984PLC004507

Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.com

March 6, 2025

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY) BSE Ltd. (Scrip Code: 500124) New York Stock Exchange Inc. (Stock Code: RDY) NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/Madam,

Ref: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

Sub: Allotment of Equity Shares on exercise of Stock Options under ESOPs

This is to inform you that the Company has allotted 11,250 equity shares of Re.1/- each of the Company, fully paid up, on March 6, 2025, to eligible employees pursuant to exercise of their Stock Options under Dr. Reddy’s Employees Stock Options Scheme, 2002.

Further, please find enclosed the details as required under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Thanking you,

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

KUMAR Digitally signed by KUMAR RANDHIR RANDHIR SINGH Date: 2025.03.06 SINGH 16:22:48 +05'30'

K Randhir Singh

Company Secretary, Compliance Officer & Head-CSR

Encl: as above

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India

==> picture [128 x 29] intentionally omitted <==

CIN: L85195TG1984PLC004507

Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.com

Details under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

==> picture [463 x 481] intentionally omitted <==

----- Start of picture text -----

1 Company name and address of Registered Office:
Dr. Reddy's Laboratories Limited
8-2-337, Road No.3, Banjara Hills, Hyderabad – 500034
2 Name of the Stock Exchanges on which the company’s shares are listed:
BSE Limited
National Stock Exchange of India Limited
New York Stock Exchange Inc. (ADRs)
NSE IFSC Limited (ADRs)
3 Filing date of the statement referred in Regulation 10(b) of the SEBI (Share Based Employee
Benefits) Regulations, 2021 with Stock Exchange:
The Schemes were institutionalised under the erstwhile the SEBI (Employee Stock Option Scheme and
Employee Stock Purchase Scheme) Guidelines, 1999 and appropriate details under Schedule V were
filed. The Schemes comply with provisions of the SEBI (Share Based Employee Benefits and Sweat
Equity) Regulations, 2021.
4 Filing Number, if any: NA
5 Title of the Scheme pursuant to which shares are issued, if any:
Dr. Reddy’s Employees Stock Options Scheme, 2002
6 Kind of security to be listed: Equity Shares
7 Par value of the shares: Re. 1/-
8 Date of issue of shares: March 6, 2025 (Date of allotment on exercise)
9 Number of shares issued: 11,250 equity shares
10 Share Certificate No., if applicable: NA
11 Distinctive number of the share, if applicable: 834444116 to 834455365
12 ISIN Number of the shares if issued in Demat: INE089A01031
13 Exercise price per share: 11,250 equity shares exercised at Re.1/- per share
14 Premium per share: 11,250 equity shares- Nil
15 Total Issued shares after this issue: 83,44,56,365 ()
16 Total Issued share capital after this issue: Rs. 83,44,56,365/-
17 Details of any lock-in on the shares: NA
18 Date of expiry of lock-in: NA
19 Whether shares identical in all respects to existing shares if not, when will they become identical?
Yes, the shares rank pari passu with the existing shares
20 Details of listing fees, if payable: NA
----- End of picture text -----*

(*) Total paid up capital after this issue: 83,44,55,365 equity shares of Re.1 each, aggregating to Rs. 83,44,55,365 (difference of 1,000 due to forfeited shares of Re. 1/- each in September 1988 on account of nonpayment of allotment money.)

KUMAR Digitally signed by KUMAR RANDHIR RANDHIR SINGH Date: 2025.03.06 SINGH 16:26:37 +05'30'